Sort   by:  
 Page size 
UnknownClinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer.
Not available
S-EPMC10209672 | biostudies-literature
UnknownRandomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer.
Not available
S-EPMC3296668 | biostudies-literature
UnknownQuality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma.
Not available
S-EPMC4803452 | biostudies-literature
UnknownPrognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data.
Not available
S-EPMC5489542 | biostudies-literature
UnknownDiagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol.
Not available
S-EPMC7880102 | biostudies-literature
Sort   by:  
 Page size